Walid Gellad
@walidgellad.bsky.social
Reposted by Walid Gellad
Data suggest Paxlovid doesn't reduce severe COVID in older, vaccinated adults
www.cidrap.umn.edu
February 21, 2025 at 11:07 PM
Reposted by Walid Gellad
Remember E. coli outbreak linked to onions in McDonald's Quarter Pounders?
FDA inspectors found dozens of violations at supplier, like:
- ignoring biofilm/debris buildup
- not using handwashing sinks
- cleaning chemicals getting on food
www.cbsnews.com/news/fda-rep...
FDA inspectors found dozens of violations at supplier, like:
- ignoring biofilm/debris buildup
- not using handwashing sinks
- cleaning chemicals getting on food
www.cbsnews.com/news/fda-rep...
FDA finds little handwashing, dirty equipment at McDonald's supplier linked to E. coli outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
www.cbsnews.com
January 10, 2025 at 10:44 PM
Remember E. coli outbreak linked to onions in McDonald's Quarter Pounders?
FDA inspectors found dozens of violations at supplier, like:
- ignoring biofilm/debris buildup
- not using handwashing sinks
- cleaning chemicals getting on food
www.cbsnews.com/news/fda-rep...
FDA inspectors found dozens of violations at supplier, like:
- ignoring biofilm/debris buildup
- not using handwashing sinks
- cleaning chemicals getting on food
www.cbsnews.com/news/fda-rep...
Reposted by Walid Gellad
Truly, one of the best changes to Medicare in decades. If you need a very expensive medicine (or a lot of medicine) and you are on Medicare you now have a hard cap on spending starting on 1/1. That is awesome.
Medicare's $2,000 prescription drug cap will take effect at the start of the new year.
The yearly limit on out-of-pocket payments, under the Inflation Reduction Act, is expected to lower millions of seniors' medical costs.
The yearly limit on out-of-pocket payments, under the Inflation Reduction Act, is expected to lower millions of seniors' medical costs.
Medicare $2,000 prescription drug cap starts Jan. 1
The yearly cap will be $2,000 in 2025.
www.axios.com
December 29, 2024 at 4:19 AM
Truly, one of the best changes to Medicare in decades. If you need a very expensive medicine (or a lot of medicine) and you are on Medicare you now have a hard cap on spending starting on 1/1. That is awesome.
Reposted by Walid Gellad
FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center
public-inspection.federalregister.gov/2024-31266.p...
More on their clinical applications here
pmc.ncbi.nlm.nih.gov/articles/PMC...
public-inspection.federalregister.gov/2024-31266.p...
More on their clinical applications here
pmc.ncbi.nlm.nih.gov/articles/PMC...
December 27, 2024 at 4:16 PM
FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center
public-inspection.federalregister.gov/2024-31266.p...
More on their clinical applications here
pmc.ncbi.nlm.nih.gov/articles/PMC...
public-inspection.federalregister.gov/2024-31266.p...
More on their clinical applications here
pmc.ncbi.nlm.nih.gov/articles/PMC...
Reposted by Walid Gellad
Some news ...
I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions.
hspp.sph.brown.edu
I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions.
hspp.sph.brown.edu
Health Services, Policy & Practice | School of Public Health | Brown University
Imagine a world where everyone has access to quality health care—regardless of their social status, ethnicity or financial situation.
hspp.sph.brown.edu
December 19, 2024 at 5:48 PM
Some news ...
I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions.
hspp.sph.brown.edu
I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions.
hspp.sph.brown.edu
Reposted by Walid Gellad
I'm looking for a third paper for a Medicaid managed care-focused panel for ASHE. DM me if interested!
Please RT, I'm new to the blue skies...
Please RT, I'm new to the blue skies...
December 16, 2024 at 8:43 PM
I'm looking for a third paper for a Medicaid managed care-focused panel for ASHE. DM me if interested!
Please RT, I'm new to the blue skies...
Please RT, I'm new to the blue skies...
Reposted by Walid Gellad
CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
December 2, 2024 at 5:38 PM
CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Reposted by Walid Gellad
When prescription drug costs are subjectively set by conflicted intermediates who profit off higher prices and misaligned incentives, the sticker shock isn’t really a shock at all. www.wsj.com/health/healt... @wsj.com
Same Drug, 2,200 Different Prices
Middlemen negotiate widely different prices for prescriptions, depending on your Medicare insurance plan.
www.wsj.com
November 26, 2024 at 4:26 PM
When prescription drug costs are subjectively set by conflicted intermediates who profit off higher prices and misaligned incentives, the sticker shock isn’t really a shock at all. www.wsj.com/health/healt... @wsj.com
Reposted by Walid Gellad
🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials.
Read more @JAMAInternalMed
jamanetwork.com/journals/jam...
Read more @JAMAInternalMed
jamanetwork.com/journals/jam...
Generalizability of Clinical Trial Findings of Novel Weight Loss Medications
This cross-sectional study investigates the extent to which individuals meeting label criteria for novel weight loss medications may not have been included in pivotal trials.
jamanetwork.com
November 26, 2024 at 7:23 PM
🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials.
Read more @JAMAInternalMed
jamanetwork.com/journals/jam...
Read more @JAMAInternalMed
jamanetwork.com/journals/jam...
Reposted by Walid Gellad
Reprising this from my AEI colleague Ben Ippolito on the cost of Medicare coverage for GLP-1s. CMS appears to see writing on wall here: As additional indications are approved, most Medicare recipients will get coverage for other co-morbidities. Also, Semaglutide subject to IRA price controls in 2027
November 26, 2024 at 3:24 PM
Reprising this from my AEI colleague Ben Ippolito on the cost of Medicare coverage for GLP-1s. CMS appears to see writing on wall here: As additional indications are approved, most Medicare recipients will get coverage for other co-morbidities. Also, Semaglutide subject to IRA price controls in 2027
Reposted by Walid Gellad
My article in @statnews.bsky.social on GLP-1 compounding: the @fda.gov needs to maintain the integrity of its authorities — and the implementation of the Drug Quality and Security Act (DQSA).
www.statnews.com/2024/11/19/f...
www.statnews.com/2024/11/19/f...
November 22, 2024 at 7:54 PM
My article in @statnews.bsky.social on GLP-1 compounding: the @fda.gov needs to maintain the integrity of its authorities — and the implementation of the Drug Quality and Security Act (DQSA).
www.statnews.com/2024/11/19/f...
www.statnews.com/2024/11/19/f...
Reposted by Walid Gellad
I do hope it sticks this time @katiepalmer.bsky.social! Nice comments from @walidgellad.bsky.social and @scottgottliebmd.bsky.social.
Bluesky is the new destination for X/Twitter’s health and science community. Here's why
#MedTwitter is migrating en masse from X to Bluesky, suddenly making it an essential hub for scientific discourse. Here's why.
www.statnews.com
November 21, 2024 at 2:42 PM
I do hope it sticks this time @katiepalmer.bsky.social! Nice comments from @walidgellad.bsky.social and @scottgottliebmd.bsky.social.
Reposted by Walid Gellad
ICYMI: Our team previously showed ⬆️prices for indomethacin suppositories. Now, we found wide variation in hospital charges for this drug - charges passed to patients b/c the suppositories are excluded from Medicare Parts B&D.
More in JAMA Network Open
jamanetwork.com/journals/jam...
More in JAMA Network Open
jamanetwork.com/journals/jam...
November 19, 2024 at 3:25 PM
ICYMI: Our team previously showed ⬆️prices for indomethacin suppositories. Now, we found wide variation in hospital charges for this drug - charges passed to patients b/c the suppositories are excluded from Medicare Parts B&D.
More in JAMA Network Open
jamanetwork.com/journals/jam...
More in JAMA Network Open
jamanetwork.com/journals/jam...
Reposted by Walid Gellad
Oral naltrexone is one of main medications doctors can turn to for treating alcohol use disorder
FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug"
www.accessdata.fda.gov/scripts/drug...
FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug"
www.accessdata.fda.gov/scripts/drug...
March 2, 2024 at 1:47 AM
Oral naltrexone is one of main medications doctors can turn to for treating alcohol use disorder
FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug"
www.accessdata.fda.gov/scripts/drug...
FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug"
www.accessdata.fda.gov/scripts/drug...
I’m not posting much here, but I’d like to point out that it is tweets like this that exaggerate study findings. Stat shouldn’t do this. This study design cannot measure impact of COVID on cognition. Rather it compares cognition in those with and without COVID/symptoms with no baseline measure.
A new study on long Covid looks at how much cognition is impaired in the months after a coronavirus infection and shows that Covid-19’s impact can be measured in the equivalent of IQ points.
www.statnews.com/2024/02/28/c...
www.statnews.com/2024/02/28/c...
‘Brain fog’ is one of Covid-19’s most daunting symptoms. A new study measures its impact
"Brain fog" is one of Covid-19’s most daunting symptoms. A new study finds the equivalent of a 3- to 9-point drop in IQ depending on infection severity.
www.statnews.com
March 2, 2024 at 5:24 PM
I’m not posting much here, but I’d like to point out that it is tweets like this that exaggerate study findings. Stat shouldn’t do this. This study design cannot measure impact of COVID on cognition. Rather it compares cognition in those with and without COVID/symptoms with no baseline measure.
Reposted by Walid Gellad
Prospective PhD students: Applications are now open for the
#PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)
#PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)
Admissions Events | School of Public Health
Prospective Bachelor's Students Register for an in-person or virtual information session for the Bachelor of Science in Public Health program through Pitt Undergraduate Admissions.
www.sph.pitt.edu
October 9, 2023 at 4:45 PM
Prospective PhD students: Applications are now open for the
#PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)
#PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)
The Department of Health Policy and Management at Pitt is hiring tenure track faculty in policy and health services research. Apply. French fries on salads.
https://cfopitt.taleo.net/careersection/pitt_faculty_external/jobdetail.ftl?job=22000867&tz=GMT-04%3A00&tzname=America%2FNew_York
https://cfopitt.taleo.net/careersection/pitt_faculty_external/jobdetail.ftl?job=22000867&tz=GMT-04%3A00&tzname=America%2FNew_York
September 27, 2023 at 2:05 AM
The Department of Health Policy and Management at Pitt is hiring tenure track faculty in policy and health services research. Apply. French fries on salads.
https://cfopitt.taleo.net/careersection/pitt_faculty_external/jobdetail.ftl?job=22000867&tz=GMT-04%3A00&tzname=America%2FNew_York
https://cfopitt.taleo.net/careersection/pitt_faculty_external/jobdetail.ftl?job=22000867&tz=GMT-04%3A00&tzname=America%2FNew_York
Reposted by Walid Gellad
Re-upping this since the health policy contingent is slowly but steadily growing:
BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed.
I created a health policy feed here:
BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed.
I created a health policy feed here:
August 16, 2023 at 9:25 PM
Re-upping this since the health policy contingent is slowly but steadily growing:
BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed.
I created a health policy feed here:
BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed.
I created a health policy feed here:
Reposted by Walid Gellad
You should check this out - use the #healthpolicy hashtag to get posts to go into this feed. You can also pin the feed to your dashboard so you can just see these posts (very useufl, IMO).
July 26, 2023 at 8:39 PM
You should check this out - use the #healthpolicy hashtag to get posts to go into this feed. You can also pin the feed to your dashboard so you can just see these posts (very useufl, IMO).
Reposted by Walid Gellad
Welcome, @bnrome.bsky.social ! Check out the health policy list and instructions for contributing to that feed. You can pin the feed to easily get back to it.
July 17, 2023 at 12:54 AM
Welcome, @bnrome.bsky.social ! Check out the health policy list and instructions for contributing to that feed. You can pin the feed to easily get back to it.
Original Humira’s list price grew so much that its actual price after rebates to Medicaid was zero.
(It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807194
(It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807194
July 15, 2023 at 11:56 AM
Original Humira’s list price grew so much that its actual price after rebates to Medicaid was zero.
(It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807194
(It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807194
Reposted by Walid Gellad
ICER's report on sickle cell disease🧪 is out today!
Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M
#healthpolicy
Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M
#healthpolicy
July 13, 2023 at 2:33 PM
ICER's report on sickle cell disease🧪 is out today!
Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M
#healthpolicy
Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M
#healthpolicy
“Another hospital attempted to charge a patient a facility fee of up to $350 for a telehealth visit because the doctor was on hospital property.” 🙃
#healthpolicy
https://www.statnews.com/2023/07/07/hospital-facility-fees-biden-initiative/
#healthpolicy
https://www.statnews.com/2023/07/07/hospital-facility-fees-biden-initiative/
New Biden initiative targets controversial hospital 'facility fees' that often surprise patients
A new Biden administration initiative requires hospitals to “make information about these facility fees publicly available to consumers.”
www.statnews.com
July 10, 2023 at 10:40 AM
“Another hospital attempted to charge a patient a facility fee of up to $350 for a telehealth visit because the doctor was on hospital property.” 🙃
#healthpolicy
https://www.statnews.com/2023/07/07/hospital-facility-fees-biden-initiative/
#healthpolicy
https://www.statnews.com/2023/07/07/hospital-facility-fees-biden-initiative/
Reposted by Walid Gellad
Happy to share our new piece answering the ? "What bar should CMS consider when determining what 'bona fide generic entry' means." #healthpolicy
https://www.nejm.org/doi/full/10.1056/NEJMp2304289?query=WB&cid=NEJM%20Weekend%20Briefing,%20July%208,%202023%20DM2259601_NEJM_Subscriber&bid=1665394310
https://www.nejm.org/doi/full/10.1056/NEJMp2304289?query=WB&cid=NEJM%20Weekend%20Briefing,%20July%208,%202023%20DM2259601_NEJM_Subscriber&bid=1665394310
July 9, 2023 at 3:49 PM
Happy to share our new piece answering the ? "What bar should CMS consider when determining what 'bona fide generic entry' means." #healthpolicy
https://www.nejm.org/doi/full/10.1056/NEJMp2304289?query=WB&cid=NEJM%20Weekend%20Briefing,%20July%208,%202023%20DM2259601_NEJM_Subscriber&bid=1665394310
https://www.nejm.org/doi/full/10.1056/NEJMp2304289?query=WB&cid=NEJM%20Weekend%20Briefing,%20July%208,%202023%20DM2259601_NEJM_Subscriber&bid=1665394310
Testing the waters here.
this ability to follow specific feeds based on hashtags right from the app is a big plus.
Although not to ruin things but I see potential for topic specific ads in specific feeds.
this ability to follow specific feeds based on hashtags right from the app is a big plus.
Although not to ruin things but I see potential for topic specific ads in specific feeds.
Welcome! Lists aren't really a thing yet, but "feeds" are—here are feeds for health policy and econ twitter (instructions in the descriptions)
https://bsky.app/profile/did:plc:xqbbs34shcevzm326a4rvftn/feed/aaabre5ak5ddi
https://bsky.app/profile/did:plc:yw3qqfa7hrhmwbc6wyrq5u7f/feed/aaabqfmu2zuck
https://bsky.app/profile/did:plc:xqbbs34shcevzm326a4rvftn/feed/aaabre5ak5ddi
https://bsky.app/profile/did:plc:yw3qqfa7hrhmwbc6wyrq5u7f/feed/aaabqfmu2zuck
July 8, 2023 at 7:17 PM
Testing the waters here.
this ability to follow specific feeds based on hashtags right from the app is a big plus.
Although not to ruin things but I see potential for topic specific ads in specific feeds.
this ability to follow specific feeds based on hashtags right from the app is a big plus.
Although not to ruin things but I see potential for topic specific ads in specific feeds.